大盤異動 | 螞蟻"放鴿子",物業、醫藥、消費、次新股遭熱炒
uSMART盈立智投11月4日消息,正當港股打新者喜迎中籤的前夕,螞蟻集團宣佈暫緩滬港兩地的IPO,全球最大IPO變身"鴿王",一石激起千層浪!打新者紛紛感嘆:"還沒上市就虧錢",好在,部分券商宣佈與投資者共度時艱,退還全部申購手續費和融資利息,uSMART盈立證券亦第一時間通知客戶,將退還全部的費用。
不過硬幣有兩面,螞蟻暫緩上市,也一定程度上緩解了市場對資金抽水的擔憂。
縱觀週三港股大盤,一方面受美國大選的開票結果影響,恆指呈現膠着狀態,一方面是次新股、醫藥股、消費股、物業股、內循環概念股重新受到資金追逐,逆市大幅上揚。
截至14:49分,海吉亞醫療漲超12%,永泰生物-B漲超10%,康寧傑瑞製藥-B、小米集團、開拓集團漲超9%,諾誠健華-B、合景悠活、碧桂園服務、美團漲超6%,九毛九、歐康維視、佳兆業美好、保利物業、雅生活服務漲超4%。
次新股明源雲漲6.62%,最高觸及38港元,創上市以來新高,距離中金目標價40港元僅兩步之遙,打新至今,不計手續費,一手賬面賺21500港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.